neurodegenerative disease program (Evotec/Bristol-Myers Squibb)
N/A
Report date: 2025/01/26 17:36:34
NME
Base Information
Drug Nameneurodegenerative disease program (Evotec/Bristol-Myers Squibb)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A
Develop Information
Active CompaniesBristol-Myers Squibb CompanyEvotec SE
Inactive CompaniesCelgene Corp
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A